blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2311455

EP2311455 - Compounds for nonsense suppression, and methods for their use [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.05.2016
Database last updated on 14.09.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): BG, CY, HU, NL, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield, NJ 07080 / US
[2011/16]
Inventor(s)01 / Almstead, Neil
179 Longview Drive
Princeton, NJ 08540 / US
02 / Chen, Guangming
1402 Stech Drive
Bridgewater, NJ 08807 / US
03 / Karp, Gary Mitchell
37 Cartwright Drive
Princeton Junction, NJ 08550 / US
04 / Welch, Ellen
33 Hollow Brook Road
Califon, NJ 07830 / US
05 / Wilde, Richard Gerald
13 Cascades Terrace
Sommerville, NJ 08876 / US
06 / Campbell, Jeffrey Allen
328 Adams Street
Apt. 103
Bethlehem, PA 18015 / US
 [2015/29]
Former [2011/34]01 / Almstead, Neil
179 Longview Drive
Princeton, NJ 08540 / US
02 / Chen, Guangming
1402 Stech Drive
Bridgewater, NJ 08807 / US
03 / Karp, Gary Mitchell
37 Cartwright Drive
Princeton Junction, NJ 08550 / US
04 / Welch, Ellen
33 Hollow Brook Road
Califon, NJ 07830 / US
05 / Wilde, Richard Gerald
13 Cascades Terrace
Sommerville, NJ 08876 / US
06 / Campbell, Jeffrey Allen
328 Adams Street Apt. 103
Bethlehem, PA 18015 / US
Former [2011/16]01 / Almstead, Neil
179 Longview Drive
Princeton, NJ 08540 / US
02 / Chen, Guangming
1402 Stech Drive
Bridgewater, NJ 08807 / US
03 / Karp, Gary Mitchell
37 Cartwright Drive
Princeton Junction, NJ 08550 / US
04 / Welch, Ellen
33 Hollow Brook Road
Califon, NJ 07830 / US
05 / Wilde, Richard Gerald
13 Cascades Terrace
Sommerville, NJ 08876 / US
06 / Campbell, Jeffrey Allen
31 Bell Avenue
Glen Gardner, NJ 08826 / US
Representative(s)Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
[N/P]
Former [2015/29]UEXKÜLL & STOLBERG
Patentanwälte
Beselerstrasse 4
22607 Hamburg / DE
Former [2011/16]UEXKÜLL & STOLBERG
Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Application number, filing date10185130.113.10.2005
[2011/16]
Priority number, dateUS20040617653P13.10.2004         Original published format: US 617653 P
US20040617670P13.10.2004         Original published format: US 617670 P
US20040617633P13.10.2004         Original published format: US 617633 P
US20040617634P13.10.2004         Original published format: US 617634 P
US20040617655P13.10.2004         Original published format: US 617655 P
US20040624170P03.11.2004         Original published format: US 624170 P
[2011/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2311455
Date:20.04.2011
Language:EN
[2011/16]
Type: B1 Patent specification 
No.:EP2311455
Date:15.07.2015
Language:EN
[2015/29]
Search report(s)(Supplementary) European search report - dispatched on:EP17.02.2011
ClassificationIPC:A61K31/4245, A61K31/433, A61P35/00, C07D417/10, C07D277/30
[2011/16]
CPC:
C07D271/06 (EP,US); A61K31/4155 (KR); A61K31/53 (KR);
A61P1/16 (EP); A61P11/00 (EP); A61P13/12 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P19/08 (EP);
A61P21/00 (EP); A61P25/00 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/04 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P43/00 (EP);
A61P5/14 (EP); A61P7/00 (EP); A61P7/04 (EP);
A61P9/00 (EP); A61P9/10 (EP); C07D231/12 (EP,US);
C07D233/64 (EP,US); C07D249/08 (EP,US); C07D251/24 (EP,US);
C07D261/08 (EP,US); C07D263/32 (EP,US); C07D271/10 (EP,US);
C07D271/107 (EP,US); C07D277/30 (EP,US); C07D285/12 (EP,US);
C07D307/68 (EP,US); C07D333/24 (EP,US); C07D401/04 (EP,US);
C07D403/04 (EP,US); C07D405/04 (EP,US); C07D409/04 (EP,US);
C07D413/04 (EP,US); C07D413/06 (EP,US); C07D413/12 (EP,KR,US);
C07D417/04 (EP,US); C07F9/65306 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/29]
Former [2011/16]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Verbindungen zur Nonsense-Unterdrückung und Verfahren zu deren Verwendung[2011/16]
English:Compounds for nonsense suppression, and methods for their use[2011/16]
French:Composes de suppression de non-sens et procedes de leur utilisation[2011/16]
Examination procedure20.10.2011Amendment by applicant (claims and/or description)
20.10.2011Examination requested  [2011/48]
06.02.2013Despatch of a communication from the examining division (Time limit: M04)
17.06.2013Reply to a communication from the examining division
14.11.2013Communication of intention to grant the patent
12.03.2014Receipt of the translation of the claim(s)
14.03.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
10.04.2014Communication of intention to grant the patent
19.08.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
08.01.2015Communication of intention to grant the patent
15.05.2015Fee for grant paid
15.05.2015Fee for publishing/printing paid
15.05.2015Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP05815159.8  / EP1815206
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050815159) is  27.05.2008
Opposition(s)18.04.2016No opposition filed within time limit [2016/25]
Fees paidRenewal fee
06.12.2010Renewal fee patent year 03
06.12.2010Renewal fee patent year 04
06.12.2010Renewal fee patent year 05
06.12.2010Renewal fee patent year 06
25.10.2011Renewal fee patent year 07
26.10.2012Renewal fee patent year 08
30.10.2013Renewal fee patent year 09
14.10.2014Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.10.2005
AT15.07.2015
BE15.07.2015
BG15.07.2015
CY15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
ES15.07.2015
FI15.07.2015
IS15.07.2015
IT15.07.2015
LT15.07.2015
LV15.07.2015
MC15.07.2015
NL15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SI15.07.2015
SK15.07.2015
TR15.07.2015
IE13.10.2015
LU13.10.2015
GR16.10.2015
CH31.10.2015
LI31.10.2015
PT16.11.2015
[2017/39]
Former [2017/03]AT15.07.2015
BE15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
ES15.07.2015
FI15.07.2015
IS15.07.2015
IT15.07.2015
LT15.07.2015
LV15.07.2015
MC15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SI15.07.2015
SK15.07.2015
IE13.10.2015
LU13.10.2015
GR16.10.2015
CH31.10.2015
LI31.10.2015
PT16.11.2015
Former [2016/45]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
ES15.07.2015
FI15.07.2015
IS15.07.2015
IT15.07.2015
LT15.07.2015
LV15.07.2015
MC15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SI15.07.2015
SK15.07.2015
IE13.10.2015
LU13.10.2015
GR16.10.2015
CH31.10.2015
LI31.10.2015
PT16.11.2015
Former [2016/36]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
ES15.07.2015
FI15.07.2015
IS15.07.2015
IT15.07.2015
LT15.07.2015
LV15.07.2015
MC15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SI15.07.2015
SK15.07.2015
LU13.10.2015
GR16.10.2015
CH31.10.2015
LI31.10.2015
PT16.11.2015
Former [2016/34]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
ES15.07.2015
FI15.07.2015
IS15.07.2015
IT15.07.2015
LT15.07.2015
LV15.07.2015
MC15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SK15.07.2015
LU13.10.2015
GR16.10.2015
CH31.10.2015
LI31.10.2015
PT16.11.2015
Former [2016/31]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
ES15.07.2015
FI15.07.2015
IS15.07.2015
IT15.07.2015
LT15.07.2015
LV15.07.2015
MC15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SK15.07.2015
LU13.10.2015
GR16.10.2015
PT16.11.2015
Former [2016/28]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
ES15.07.2015
FI15.07.2015
IT15.07.2015
LT15.07.2015
LV15.07.2015
MC15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SK15.07.2015
LU13.10.2015
GR16.10.2015
PT16.11.2015
Former [2016/26]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
ES15.07.2015
FI15.07.2015
IT15.07.2015
LT15.07.2015
LV15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SK15.07.2015
LU13.10.2015
GR16.10.2015
PT16.11.2015
Former [2016/23]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
ES15.07.2015
FI15.07.2015
IT15.07.2015
LT15.07.2015
LV15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SK15.07.2015
GR16.10.2015
PT16.11.2015
Former [2016/22]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
ES15.07.2015
FI15.07.2015
IT15.07.2015
LT15.07.2015
LV15.07.2015
PL15.07.2015
SE15.07.2015
GR16.10.2015
PT16.11.2015
Former [2016/21]AT15.07.2015
DK15.07.2015
ES15.07.2015
FI15.07.2015
IT15.07.2015
LT15.07.2015
LV15.07.2015
PL15.07.2015
SE15.07.2015
GR16.10.2015
PT16.11.2015
Former [2016/20]AT15.07.2015
DK15.07.2015
ES15.07.2015
FI15.07.2015
LT15.07.2015
LV15.07.2015
PL15.07.2015
SE15.07.2015
GR16.10.2015
PT16.11.2015
Former [2016/11]AT15.07.2015
ES15.07.2015
FI15.07.2015
LT15.07.2015
LV15.07.2015
PL15.07.2015
SE15.07.2015
GR16.10.2015
PT16.11.2015
Former [2016/10]ES15.07.2015
FI15.07.2015
LT15.07.2015
LV15.07.2015
PL15.07.2015
SE15.07.2015
GR16.10.2015
PT16.11.2015
Former [2016/09]FI15.07.2015
LT15.07.2015
LV15.07.2015
GR16.10.2015
Former [2016/07]LT15.07.2015
Documents cited:Search[X]US3947263  (BROUWER WALTER G, et al) [X] 1 * column 6; compounds G,O *;
 [X]US3964896  (BROUWER WALTER G, et al) [X] 1 * column 9 - column 10; examples 29-31 *;
 [X]US4210762  (HOWE ROBERT K [US]) [X] 1 * examples 5,6,8 *;
 [X]DE3819037  (HOECHST AG [DE]) [X] 1-3 * example 43; claim - *;
 [X]EP0838453  (EISAI CO LTD [JP]) [X] 1-14 * page 2, line 10 - line 27; examples 18,19,22,23; claims 1,8-10 *;
 [X]EP0889032  (EISAI CO LTD [JP]) [X] 1-14 * page 3, line 13 - line 30; examples 1,62,63; claims 1,14-19 *;
 [X]WO02068417  (NPS PHARMA INC [US], et al) [X] 1-14 * page 46; examples 10,B147,B265; claims 1,7,8,10,14 *;
 [X]WO2004072050  (NOVARTIS AG [CH], et al) [X] 1-14 * examples 13-16; claim - *;
 [X]  - MACDONALD G J ET AL, "Design and Synthesis of trans-3(2-(4-((3-(3-(5-Methyl-1,2,4-oxadiozol yl))-phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-te trahydro1H-3-benzazepine (SB-414796): A Potent and Selective Dopamine D.sub.3 Receptor Antagonist", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, (20031106), vol. 46, no. 23, doi:10.1021/JM030817D, ISSN 0022-2623, pages 4952 - 4964, XP002994764 [X] 1 * Schemes 1 and 2 *; page 4954, column r, line 25, paragraph 2 - line 28; compounds 31,33,56 *

DOI:   http://dx.doi.org/10.1021/jm030817d
by applicantUS4892538
 WO9325673
 US5283187
 US5681746
 US2003023185
 US6800604
 US6800731
    - ZAMBETTI, G.P.; LEVINE, A., FASEB, (1993), vol. 7, pages 855 - 865
    - HOLLSTEIN, M. ET AL., NUCLEIC ACIDS RES., (1994), vol. 22, pages 3551 - 55
    - KOSHLAND, D., SCIENCE, (1993), vol. 262, page 1953
    - SLEAT, EUR. J. PED. NEUROL., (2001), vol. 5, no. A, pages 57 - 62
    - BEDWELL, NAT. MED., (1997), vol. 3, pages 1280 - 1284
    - HOWARD, NAT. MED., (1996), vol. 2, pages 467 - 469
    - BARTON-DAVIS, J. CLIN. INVEST., (1999), vol. 104, pages 375 - 381
    - KUBO ET AL., TET. LETT., (1986), vol. 27, page 4277
    - MOSS ET AL., J. MED. CHEM., (1988), vol. 31, pages 786 - 790
    - KAMIKAWA ET AL., J. CHEM. SOC. CHEM. COMMUN., (1988), page 195
    - MOSS ET AL., J. MED. CHERN., (1988), vol. 31, pages 786 - 790
    - MASUDA ET AL., TOKAI J EXP CLIN MED., (2000), vol. 25, no. 2, pages 69 - 77
    - OH ET AL., MOL CELLS, (2000), vol. 10, no. 3, pages 275 - 80
    - LI ET AL., LAB INVEST, (2000), vol. 80, no. 4, pages 493 - 9
    - YANG ET AL., ZHONGHUA ZHONG LIU ZA ZHI, (1999), vol. 21, no. 2, pages 114 - 8
    - FINKELSTEIN ET AL., MOL DIAGN., (1998), vol. 3, no. 1, pages 37 - 41
    - KAJIYAMA ET AL., DIS ESOPHAGUS., (1998), vol. 11, no. 4, pages 279 - 83
    - KAWAMURA ET AL., LEUK RES., (1999), vol. 23, no. 2, pages 115 - 26
    - RADIG ET AL., HUM PATHOL., (1998), vol. 29, no. 11, pages 1310 - 6
    - SCHUYER ET AL., INT J CANCER, (1998), vol. 76, no. 3, pages 299 - 303
    - WANG-GOHRKE ET AL., ONCOL REP., (1998), vol. 5, no. 1, pages 65 - 8
    - FULOP ET AL., J REPROD MED., (1998), vol. 43, no. 2, pages 119 - 27
    - NINOMIYA ET AL., J DERMATOL SCI., (1997), vol. 14, no. 3, pages 173 - 8
    - HSIEH ET AL., CANCER LETT., (1996), vol. 100, no. 1-2, pages 107 - 13
    - RALL ET AL., PANCREAS, (1996), vol. 12, no. 1, pages 10 - 7
    - FUKUTOMI ET AL., NIPPON RINSHO, (1995), vol. 53, no. 11, pages 2764 - 8
    - FREBOURG ET AL., AM J HUM GENET., (1995), vol. 56, no. 3, pages 608 - 15
    - DOVE ET AL., CANCER SURV., (1995), vol. 25, pages 335 - 55
    - ADAMSON ET AL., BR J HAEMATOL., (1995), vol. 89, no. 1, pages 61 - 6
    - GRAYSON ET AL., AM J PEDIATR HEMATOL ONCOL., (1994), vol. 16, no. 4, pages 341 - 7
    - LEPELLEY ET AL., LEUKEMIA, (1994), vol. 8, no. 8, pages 1342 - 9
    - MCINTYRE ET AL., J CLIN ONCOL., (1994), vol. 12, no. 5, pages 925 - 30
    - HORIO ET AL., ONCOGENE, (1994), vol. 9, no. 4, pages 1231 - 5
    - NAKAMURA ET AL., JPN J CANCER RES., (1992), vol. 83, no. 12, pages 1293 - 8
    - DAVIDOFF ET AL., ONCOGENE, (1992), vol. 7, no. 1, pages 127 - 33
    - ISHIOKA ET AL., BIOCHEM BIOPHYS RES COMMUN., (1991), vol. 177, no. 3, pages 901 - 6
    - Harrison's Principles of Internal Medicine, (2001), pages 491 - 762
    - LIE; MACDONALD, DEVELOPMENT, (1999), vol. 126, no. 22, pages 4989 - 4996
    - LIE; MACDONALD, BIOCHEM. BIOPHYS. RES. COMMUN, (2000), vol. 270, no. 2, pages 473 - 481
    - YANG ET AL., HUM. MOL. GENET., (1993), vol. 2, no. 8, pages 1253 - 1261
    - HOWARD ET AL., NAT. MED., (1996), vol. 2, no. 4, pages 467 - 469
    - TONKINSON ET AL., CANCER INVESTIGATION, (1996), vol. 14, no. 1, pages 54 - 65
    - WU ET AL., J. BIOL. CHEM., (1987), vol. 262, pages 4429 - 4432
    - WAGNER ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, pages 3410 - 3414
    - ANDERSON ET AL., SCIENCE, (1992), vol. 256, pages 808 - 813
    - LUCA, L. D.; GIACOMELLI, G.; RIU, A., J. ORG. CHEM., (2001), vol. 66, no. 20, pages 6823 - 6825
    - FREEDMAN ET AL., GASTROENTEROLOGY, (2001), vol. 121, no. 4, pages 950 - 7
    - BERNHARD ET AL., EXP LUNG RES, (2001), vol. 27, no. 4, pages 349 - 66
    - STOTLAND ET AL., PEDIATR PULMONOL, (2000), vol. 30, no. 5, pages 413 - 24
    - CONNOLLY ET AL., J NEUROIMMUNOL, (2002), vol. 127, no. 1-2, pages 80 - 7
    - GARVEY ET AL., GENOMICS, (2002), vol. 79, no. 2, pages 146 - 9
    - NAKAMURA ET AL., NEUROMUSCUL DISORD, (2001), vol. 11, no. 3, pages 251 - 9
    - DUBOWITZ ET AL., NEURORNUSCUL DISORD, (2000), vol. 10, no. 4-5, pages 292 - 8
    - PILLERS ET AL., LARYNGOSCOPE, (1999), vol. 109, no. 8, pages 1310 - 2
    - KRAMER ET AL., NEUROMUSCUL DISORD, (1998), vol. 8, no. 8, pages 542 - 50
    - NAKAMURA ET AL., AM J PHYSIOL CELL PHYSIOL, (2001), vol. 281, no. 2, pages C690 - 9
    - SCHLENKER; BURBACH, J APPL PHYSIOL, (1991), vol. 71, no. 5, pages 1655 - 62
    - GASCHEN; BURGUNDER, ACTA NEUROPATHOL (BERL), (2001), vol. 101, no. 6, pages 591 - 600
    - FLETCHER ET AL., NEURORNUSCUL DISORD, (2001), vol. 11, no. 3, pages 239 - 43
    - VALENTINE ET AL., AM J MED GENET, (1992), vol. 42, no. 3, pages 352 - 6
    - CHAMBERLAIN; BENIAN, CURR BIOL, (2000), vol. 10, no. 21, pages R795 - 7
    - CULETTE; SATTELLE, HUM MOL GENET, (2000), vol. 9, no. 6, pages 869 - 77
    - AJI ET AL., CIRCULATION, (1997), vol. 95, no. 2, pages 430 - 7
    - FANTAPPIE ET AL., LIFE SCI, (1992), vol. 50, no. 24, pages 1913 - 24
    - RICHARDSON ET AL., ATHEROSCLEROSIS, (1998), vol. 138, no. 1, pages 135 - 46
    - HASLER-RAPACZ ET AL., AM J MED GENET, (1998), vol. 76, no. 5, pages 379 - 86
    - TSUTSUMI ET AL., ARZNEIMITTELFORSCHUNG, (2000), vol. 50, no. 2, pages 118 - 21
    - HARSCH ET AL., BR J PHARMACOL, (1998), vol. 124, no. 2, pages 227 - 82
    - TANAKA ET AL., ATHEROSCLEROSIS, (1995), vol. 114, no. 1, pages 73 - 82
    - VAIL; MACEWEN, CANCER INVEST, (2000), vol. 18, no. 8, pages 781 - 92
    - ROTH, VIVO, (1994), vol. 8, no. 5, pages 755 - 69
    - MORRIS ET AL., J LA STATE MED SOC, (1998), vol. 150, no. 4, pages 179 - 85
    - HOSOKAWA ET AL., TRANSGENIC RES, (2001), vol. 10, no. 5, pages 471 - 8
    - KADO ET AL., CANCER RES, (2001), vol. 61, no. 6, pages 2395 - 8
    - WANG ET AL., INT J PANCREATOL, (2001), vol. 29, no. 1, pages 37 - 46
    - GHANEH ET AL., GENE THER, (2001), vol. 8, no. 3, pages 199 - 208
    - BRYANT ET AL., LAB INVEST, (2000), vol. 80, no. 4, pages 553 - 73
    - HOUGH ET AL., PROC NATL ACAD SCI USA, (1998), vol. 95, no. 23, pages 13853 - 8
    - HERBER ET AL., J VIROL, (1996), vol. 70, no. 3, pages 1873 - 81
    - FODDE; SMITS, TRENDS MOL MED, (2001), vol. 7, no. 8, pages 369 - 73
    - KURAGUCHI ET AL., ONCOGENE, (2000), vol. 19, no. 50, pages 5755 - 63
    - CICHOWSKI ET AL., SEMIN CANCER BIOL, (1996), vol. 7, no. 5, pages 291 - 8
    - HOWES ET AL., INVEST OPHTHALMOL VIS SCI, (1994), vol. 35, no. 2, pages 342 - 51
    - WINDLE ET AL., NATURE, (1990), vol. 343, no. 6259, pages 665 - 9
    - NISHIDA ET AL., CURR EYE RES, (1981), vol. 1, no. 1, pages 53 - 5
    - KOBAYASHI ET AL., ACTA NEUROPATHOL (BERL), (1982), vol. 57, no. 2-3, pages 203 - 8
    - SCHARNHORST ET AL., CELL GROWTH DIFFER, (1997), vol. 8, no. 2, pages 133 - 43
    - MESFIN; BREECH, LAB ANIM SCI, (1996), vol. 46, no. 3, pages 321 - 6
    - MURPHY ET AL., ANTICANCER RES, (1987), vol. 7, no. 4B, pages 717 - 9
    - VOLLRATH ET AL., PROC NATL ACAD SCI USA, (2001), vol. 98, no. 22, pages 12584 - 9
    - HANITZSCH ET AL., ACTA ANAT (BASEL), (1998), vol. 162, no. 2-3, pages 119 - 26
    - JAISSLE ET AL., INVEST OPHTHALMOL VIS SCI, (2001), vol. 42, no. 2, pages 506 - 13
    - LAI ET AL., AM J PATHOL, (1980), vol. 98, no. 1, pages 281 - 4
    - KLOEHN ET AL., HORM METAB RES, (2001), vol. 33, no. 7, pages 394 - 401
    - VIERLING, BEST PRACT RES CLIN GASTROENTEROL, (2001), vol. 15, no. 4, pages 591 - 610
    - REIPERT ET AL., 7HROMB HAEMOST, (2000), vol. 84, no. 5, pages 826 - 32
    - JARVIS ET AL., THROMB HAEMOST, (1996), vol. 75, no. 2, pages 318 - 25
    - BI ET AL., NAT GENET, (1995), vol. 10, no. 1, pages 119 - 21
    - GALLO-PENN ET AL., HUM GENE THER, (1999), vol. 10, no. 11, pages 1791 - 802
    - CONNELLY ET AL., BLOOD, (1998), vol. 91, no. 9, pages 3273 - 81
    - SNYDER ET AL., NAT MED, (1999), vol. 5, no. 1, pages 64 - 70
    - WANG ET AL., PROC NATL ACAD SCI USA, (1997), vol. 94, no. 21, pages 11563 - 6
    - FANG ET AL., GENE THER, (1996), vol. 3, no. 3, pages 217 - 22
    - MOUNT ET AL., BLOOD, (2002), vol. 99, no. 8, pages 2670 - 6
    - KAY ET AL., PROC NATL ACAD SCI USA, (1994), vol. 91, no. 6, pages 2353 - 7
    - LOZIER ET AL., BLOOD, (1999), vol. 93, no. 6, pages 1875 - 81
    - SANDERS ET AL., LAB INVEST, (1988), vol. 59, no. 4, pages 443 - 52
    - NICHOLS ET AL., PROC NATL ACAD SCI USA, (1995), vol. 92, no. 7, pages 2455 - 9
    - JOHNSON; BOWIE, J LAB CLIN MED, (1992), vol. 120, no. 4, pages 553 - 8
    - BRINKHOUS ET AL., MAYO CLIN PROC, (1991), vol. 66, no. 7, pages 733 - 42
    - LEWIS ET AL., BLOOD, (1998), vol. 91, no. 6, pages 2152 - 6
    - RAJA ET AL., BR J HAEMATOL, (1994), vol. 86, no. 1, pages 156 - 62
    - SKOW ET AL., CELL, (1983), vol. 34, no. 3, pages 1043 - 52
    - BUSHINSKY ET AL., KIDNEY INT, (1999), vol. 55, no. 1, pages 234 - 43
    - BUSHINSKY ET AL., KIDNEY INT, (1995), vol. 48, no. 6, pages 1705 - 13
    - GRASES ET AL., SCAND J UROL NEPHROL, (1998), vol. 32, no. 4, pages 261 - 5
    - BURGESS ET AL., UROL RES, (1995), vol. 23, no. 4, pages 239 - 42
    - KUMAR ET AL., J UROL, (1991), vol. 146, no. 5, pages 1384 - 9
    - OKADA ET AL., HINYOKIKA KIYO, (1985), vol. 31, no. 4, pages 565 - 77
    - BLUESTONE ET AL., LAB INVEST, (1975), vol. 33, no. 3, pages 273 - 9
    - JONES ET AL., J UROL, (1991), vol. 145, no. 4, pages 868 - 74
    - ITATANI ET AL., INVEST UROL, (1979), vol. 17, no. 3, pages 234 - 40
    - BARLOW ET AL., PROC NATL ACAD SCI USA, (1999), vol. 96, no. 17, pages 9915 - 9
    - INOUE ET AL., CANCER RES, (1986), vol. 46, no. 8, pages 3979 - 82
    - BROOKS ET AL., PROC NATL ACAD SCI U S A, (2002), vol. 99, no. 9, pages 6216 - 21
    - MONROY ET AL., BONE, (2002), vol. 30, no. 2, pages 352 - 9
    - VOGLER ET AL., PEDIATR DEV PATHOL., (2001), vol. 4, no. 5, pages 421 - 33
    - VOGLER ET AL., PEDIATR RES., (2001), vol. 49, no. 3, pages 342 - 8
    - WOLFE ET AL., MOL THER., (2000), vol. 2, no. 6, pages 552 - 6
    - MATZNER ET AL., GENE THER., (2002), vol. 9, no. 1, pages 53 - 63
    - SANGO ET AL., NEUROPATHOL APPL NEUROBIOL., (2002), vol. 28, no. 1, pages 23 - 34
    - BHATTACHARYYA ET AL., GLYCOBIOLOGY, (2001), vol. 11, no. 1, pages 99 - 10
    - BHAUMIK ET AL., GLYCOBIOLOGY, (1999), vol. 9, no. 12, pages 1389 - 96
    - D'HOOGE ET AL., BRAIN RES., (1999), vol. 847, no. 2, pages 352 - 6
    - D'HOOGE ET AL., NEUROSCI LETT., (1999), vol. 273, no. 2, pages 93 - 6
    - JALANKO ET AL., HUM MOL GENET., (1998), vol. 7, no. 2, pages 265 - 72
    - CRAWLEY ET AL., J CLIN INVEST., (1998), vol. 101, no. 1, pages 109 - 19
    - NORRDIN ET AL., BONE, (1995), vol. 17, no. 5, pages 485 - 9
    - MARCH ET AL., ACTA NEUROPATHOL (BERL)., (1997), vol. 94, no. 2, pages 164 - 72
    - OTTERBACH; STOFFEL, CELL, (1995), vol. 81, no. 7, pages 1053 - 6
    - JOLLY ET AL., BIRTH DEFECTS ORIG ARCTIC SER., (1975), vol. 11, no. 6, pages 273 - 8
    - KWIATKOWSKI ET AL., HUM MOL GENET., (2002), vol. 11, no. 5, pages 525 - 34
    - KOBAYASHI ET AL., PROC NATL ACAD SCI U S A., (20010717), vol. 98, no. 15, pages 8762 - 7
    - HINO, NIPPON RINSHO, (2000), vol. 58, no. 6, pages 1255 - 61
    - MIZUGUCHI ET AL., J NEUROPATHOL EXP NEUROL., (2000), vol. 59, no. 3, pages 188 - 9
    - HINO ET AL., PROG EXP TUMOR RES., (1999), vol. 35, pages 95 - 108
    - ONDA ET AL., J CLIN INVEST., (1999), vol. 104, no. 6, pages 687 - 95
    - SICINSKI ET AL., SCIENCE, (1989), vol. 244, no. 4912, pages 1578 - 1580
    - BARTON-DAVIS ET AL., J. CLIN. INVEST., (1999), vol. 104, no. 4, pages 375 - 381
    - MOAZED; NOLLER, NATURE, (1978), vol. 327, no. 6121, pages 389 - 394
    - WOODCOCK ET AL., EMBO J., (1991), vol. 10, no. 10, pages 3099 - 3103
    - SCHROEDER ET AL., EMBO J., (2000), vol. 19, pages 1 - 9
 US20020390747
 WO2003US19760
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.